| Trial ID: | L3454 |
| Source ID: | NCT01295073
|
| Associated Drug: |
Trientine Hydrochloride
|
| Title: |
Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Macular Edema Following Cataract Surgery
|
| Interventions: |
DRUG: Trientine Hydrochloride|OTHER: For Arm B there is no therapeutic intervention other than standard of care, which is cataract surgery.
|
| Outcome Measures: |
Primary: Change in retinal thickness measurements by Optical Coherence Tomography (OCT) from screening to Day 28 between subjects undergoing surgery with and without Trientine use., Screening, Day 28 | Secondary: Secondary analyses will involve evaluations of the change in visual acuity and fundus photography results from screening to Day 28., Screening, Day 28
|
| Sponsor/Collaborators: |
Sponsor: University of British Columbia
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2018-05-09
|
| Locations: |
Univeristy of British Columbia/Vancouver Coastal Health Authority - Eye Care Center, Vancouver, British Columbia, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT01295073
|
